{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:18:39Z","timestamp":1778642319518,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","award":["825575"],"award-info":[{"award-number":["825575"]}],"id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cca.2024.120111","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T20:16:34Z","timestamp":1735071394000},"page":"120111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Determination of new biomarkers for diagnosis of pyridoxine dependent epilepsy in human plasma and urine by liquid chromatography-mass spectrometry"],"prefix":"10.1016","volume":"567","author":[{"given":"Roberta","family":"Damiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Della Bona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Bettiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"la Marca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.120111_b0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2015.12.013","article-title":"Pyridoxine-dependent epilepsy: an expanding clinical spectrum","volume":"59","author":"van Karnebeek","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.cca.2024.120111_b0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jimd.12045","article-title":"The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: A common epileptic encephalopathy","volume":"42","author":"Coughlin","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2024.120111_b0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jimd.12332","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","volume":"44","author":"Coughlin","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2024.120111_b0020","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.1038\/s41598-019-47882-2","article-title":"Simultaneous quantification of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate, pipecolic acid and alpha-aminoadipic acid in pyridoxine-dependent epilepsy","volume":"9","author":"Xue","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.120111_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jchromb.2016.02.043","article-title":"A novel method for simultaneous quantification of alpha-aminoadipic semialdehyde\/piperideine-6-carboxylate and pipecolic acid in plasma and urine","volume":"1017\u20131018","author":"Yuzyuk","year":"2016","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.cca.2024.120111_b0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneumeth.2009.07.019","article-title":"Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC-MS\/MS for pyridoxine-dependent seizures and folinic acid-responsive seizures","volume":"184","author":"Sadilkova","year":"2009","journal-title":"J. Neurosci. Methods."},{"key":"10.1016\/j.cca.2024.120111_b0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10545-011-9443-0","article-title":"The measurement of urinary \u03941-piperideine-6-carboxylate, the alter ego of \u03b1-aminoadipic semialdehyde, in Antiquitin deficiency","volume":"25","author":"Struys","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2024.120111_b0040","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-1094","article-title":"Pyridoxine-dependent epilepsy with elevated urinary \u03b1-amino adipic semialdehyde in molybdenum cofactor deficiency","volume":"130","author":"Struys","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.cca.2024.120111_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2013.10.032","article-title":"Determination of urinary alpha-aminoadipic semialdehyde by LC-MS\/MS in patients with congenital metabolic diseases","volume":"944","author":"Ferrer-L\u00f3pez","year":"2014","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.cca.2024.120111_b0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s40064-016-1809-1","article-title":"Simultaneous detection of lysine metabolites by a single LC-MS\/MS method: monitoring lysine degradation in mouse plasma","volume":"5","author":"Pena","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.cca.2024.120111_b0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2013.07.017","article-title":"S.M.Preliminary investigation of the use of newborn dried blood spots for screening pyridoxine-dependent epilepsy by LC-MS\/MS","volume":"110","author":"Jung","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2024.120111_b0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fped.2019.00337","article-title":"The effects of a single oral dose of pyridoxine on alpha-aminoadipic semialdehyde, piperideine-6-carboxylate, pipecolic acid, and alpha-aminoadipic acid levels in pyridoxine-dependent epilepsy","volume":"7","author":"Wang","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.cca.2024.120111_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm1366","article-title":"Mutations in antiquitin in individuals with pyridoxine-dependent seizures","volume":"12","author":"Mills","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2024.120111_b0070","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.cca.2024.120111_b0075","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10545-012-9466-1","article-title":"Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency","volume":"35","author":"Mills","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2024.120111_b0080","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2583215","article-title":"Biomarker profiling for pyridoxine dependent epilepsy in dried blood spots by HILIC-ESI-MS","volume":"2018","author":"Mathew","year":"2018","journal-title":"Int. J. Anal. Chem."},{"key":"10.1016\/j.cca.2024.120111_b0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cca.2014.11.014","article-title":"Determination of plasma pipecolic acid by an easy and rapid liquid chromatography-tandem mass spectrometry method","volume":"440","author":"Semeraro","year":"2015","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.cca.2024.120111_b0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/adc.2006.103192","article-title":"Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels","volume":"92","author":"Bok","year":"2007","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cca.2024.120111_b0095","first-page":"e3841","article-title":"Pipecolic acid quantification using gas chromatography-coupled mass spectrometry","volume":"10","author":"Yu","year":"2020","journal-title":"BioProtoc."},{"key":"10.1016\/j.cca.2024.120111_b0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jimd.12059","article-title":"Identification of a novel biomarker for pyridoxine-dependent epilepsy: Implications for newborn screening","volume":"42","author":"Wempe","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cca.2024.120111_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113739","article-title":"Identification of new biomarkers of pyridoxine-dependent epilepsy by GC\/MS-based urine metabolomics","volume":"604","author":"Kuhara","year":"2020","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cca.2024.120111_b0110","doi-asserted-by":"crossref","unstructured":"Y. Khalil, E. Footitt, R. Vootukuri, M.F. Wempe, C.R. Coughlin 2nd, S. Batzios, M.P. Wilson, V. Ko\u017eich, P.T. Clayton, P.B. Mills, Assessment of urinary 6-oxo-pipecolic acid as a biomarker for ALDH7A1 deficiency, J. Inherit. Metab. Dis. 2024 Jul 22. https:\/\/doi.org\/10.1002\/jimd.12783. Online ahead of print.","DOI":"10.1002\/jimd.12783"},{"key":"10.1016\/j.cca.2024.120111_b0115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148272","article-title":"Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy","volume":"131","author":"Engelke","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2024.120111_b0120","unstructured":"Food and Drug Administration, ICH guideline M10 Bioanalytical Method Validation And Study Sample Analysis - Guidance For Industry. https:\/\/www.fda.gov\/media\/162903\/download, 2022 (accessed 13 October 2024)."},{"key":"10.1016\/j.cca.2024.120111_b0125","unstructured":"European Medicines Agency, ICH guideline Q2(R2) on validation of analytical procedures. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-q2r2-validation-analytical-procedures-step-2b_en.pdf (accessed 13 October 2024)."},{"key":"10.1016\/j.cca.2024.120111_b0130","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(84)90906-1","article-title":"Pyridoxal-5'-phosphate concentration as marker for vitamin-B6-dependent seizures in the newborn","volume":"2","author":"Shin","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2024.120111_b0135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ymgme.2004.04.010","article-title":"Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders","volume":"82","author":"Peduto","year":"2004","journal-title":"Mol. Genet. Metab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124023647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124023647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:54:23Z","timestamp":1778640863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124023647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":27,"alternative-id":["S0009898124023647"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.120111","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of new biomarkers for diagnosis of pyridoxine dependent epilepsy in human plasma and urine by liquid chromatography-mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.120111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120111"}}